SGLT2i as fourth-line therapy and risk of mortality, end-stage renal diseases and cardiovascular diseases in patients with type 2 diabetes mellitus
Carlos King Ho Wong, Eric Ho Man Tang, Kenneth K. C. Man, Esther W. Chan, Ian Chi Kei Wong, Cindy Lo Kuen Lam
Topics & Concepts
MedicineHazard ratioInternal medicineDiabetes mellitusProportional hazards modelStroke (engine)InsulinType 2 Diabetes MellitusType 2 diabetesPopulationCohortEnd stage renal diseaseCohort studyDiseaseEndocrinologyConfidence intervalEnvironmental healthMechanical engineeringEngineeringDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes